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Available online 8 December 2015Background: A speciﬁc non-motor impairment in Parkinson's disease (PD) concerns difﬁculties to accurately
identify facial emotions. Findings are numerous but very inconsistent, ranging from general discrimination def-
icits to problems for speciﬁc emotions up to no impairment at all. By contrast, only a few studies exist about emo-
tion experience, altered affective traits and states in PD.
Objective: To investigate the decoding capacity for affective facial expressions, affective experience of emotion-
eliciting images and affective personality traits in PD.
Methods: The study sample included 25 patients with mild to moderate symptom intensity and 25 healthy con-
trols (HC) of both sexes. The participants were shown pictures of facial expressions depicting disgust, fear, and
anger aswell as disgusting and fear-relevant scenes. Additionally, they answered self-report scales for the assess-
ment of affective traits.
Results: PD patients had more problems in controlling anger and disgust feelings than HC. Higher disgust sensi-
tivity in PD was associated with lower functioning in everyday life and lower capacity to recognize angry faces.
Furthermore, patients reported less disgust towards poor hygiene and spoiled food and they stated elevated anx-
iety. However, the clinical group displayed intact facial emotion decoding and emotion experience. Everyday life
functionality was lowered in PD and decreased with stronger motor impairment. Furthermore, disease duration
was negatively associated to correct classiﬁcation of angry faces.
Conclusions: Our data indicate that problems with emotion regulation may appear already in earlier disease
stages of PD. By contrast, PD patients showed appropriate emotion recognition and experience. However, data
also point to a deterioration of emotion recognition capacitywith the course of the disease. Compensatorymech-
anisms in PD patients with less advanced disease are discussed.









A clinical diagnosis of Parkinson's disease (PD) is based upon motor
symptoms, such as bradykinesia, rigidity, and resting tremor, which
usually arise unilaterally, and spread to the opposite side of the body
with progression of this neurodegenerative disease. Typical PD symp-
toms result from cell death in multiple brain regions, particularly
brain stem nuclei and dopamine-generating cells in the substantia
nigra [1,2]. In addition to classic motor dysfunction PD is characterized
by a progressive pattern of neuropsychological impairment including
abnormal emotion processing [3].
Numerous studies have been conducted to analyze PD-related ca-
pacity to accurately identify emotions in others' facial expressions, butity of Graz, Department of
. This is an open access article underﬁndings are very inconsistent. General discrimination deﬁcits [4–6],
problems for speciﬁc emotions [7–12] as well as no impairment at all
[13–17] have been reported.
Differences in facial emotion recognition in PD at least partially are a
result of moderating factors such as emotion assessment, stage of dis-
ease,medication status, or comorbid depression [7,18]. Symptom sever-
ity of patients greatly varies between studies, which is correlated with
different visual and executive dysfunctions [10]. In themajority of stud-
ies patients received dopamine replacement therapy [18]. Only few
studies included non-medicated patients, who were in early stages of
PD [4,6,12] or withdrawn from their medication during the study [11].
A study by Péron et al. [12] using vocal stimuli have found worse recog-
nition of emotional prosody in PD patients whowere ‘on’ dopamine re-
placement therapy than those who were ‘off’. Generally, comorbid
disorders such as depression could have a confounding effect on the
decoding of facial affect. In some studies, authors did not exclude pa-
tients with mild depressive symptoms, which makes it difﬁcult tothe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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icit in emotion recognition abilities, this may be related to depression.
Impaired decoding of affective facial expressions of disgust, anger
and fear has been reported repeatedly for PD [4,8,12] and for these emo-
tions speciﬁc recognition deﬁcits were pointed out in several studies
[11,19]. Speciﬁc emotion recognition deﬁcits were considered as a con-
sequence of dysfunctions in brain regions that are involved in decoding
of these facial emotions (e.g., basal ganglia and insula for thedecoding of
facial disgust) [19].
In contrast to the multitude of studies on facial emotion recognition
only a few studies exist on emotional experience and mood patterns in
PD. Findings of those studies which combined self-report with electro-
cortical and startle measures point to a lowered intensity of aversive
feelings in PD patients [20,21,22]. In contrast, Dietz et al. [23] observed
normal sympathetic arousal in PD patients who viewed affective pic-
tures. Additionally, Vicente et al. [24] found that patients even with ad-
vanced PD did not differ from healthy controls in their emotional
reactivity to emotion-inducing ﬁlm excerpts.
Furthermore, information about alterations of affective traits in PD
patients is limited. In a review, Poletti and Bonuccelli [25] concluded
that PD patients present a personality proﬁle characterized by increas-
ing inﬂexibility and apathy (e.g., lowered novelty seeking, increased
harm avoidance) on the one side and diminished inhibitory control on
the other side (see also Weintraub et al. [26]).
The aim of this study was to assess the decoding capacity for the af-
fective facial expressions of fear, disgust and anger, related affective per-
sonality traits and affective states of fear and disgust in response to
emotion-eliciting images in patients suffering from idiopathic PD. As it
is known that IAPS scenes which should induce anger usually produce
mixed emotions we did not include investigation of anger state as a tar-
get emotion.
We expected lowered recognition capacity for the facial emotions of
disgust, fear and anger, lowered emotion experience (disgust, and fear)
and decreased trait disgust, anxiety and anger in PD patients. This as-
sumption is based on previous ﬁndings regarding emotion recognition
deﬁcits and related dysfunctions of the neuronal substrate for disgust,
fear and anger processing in PD [11,19,27]. Furthermore, ﬂattened emo-
tional responses and decreased affective traits has been reported in PD
[19,20,24]. Findings byMacías et al. [28] displayed lower levels of exter-
nal expression of anger in PD patients compared to healthy controls.
Whereas, disgust proneness (the tendency of a person to experience
disgust across different situations) and disgust sensitivity (the tendency
of a person to experience one's own disgust feelings as aversive and un-
controllable) in PD has only been investigated by our working group
thus far [29].
Additionally, we were interested in the relationship between affec-
tive traits (the disposition to respond to speciﬁc classes of stimuli in a
predetermined, affect-based manner) and affective states (subjective
intensity evaluation of the target emotion of an emotion category) in
PD. Findings of previous studies have revealed associations between
the experience of speciﬁc emotions and affective traits in different clin-
ical groups and healthy controls [30,31].
Finally, we planned to assess if the capacity in emotion recognition,
emotion experience and affective traits are associated with measures
of PD symptom severity and duration. Previous results about connec-
tions between disease severity and impaired emotion recognition are
inconsistent but have been rather weak [7].
2. Methods and materials
2.1. Participants
Twenty-ﬁve symptomatic patients with idiopathic PD (15 males, 10
females) and 25 healthy controls (HC; 15males, 10 females) participat-
ed in the study. All patients were recruited and diagnosed with idio-
pathic PD by neurologists of the University Hospital in Graz (Austria).Written informed consent was obtained from each individual. The
study was carried out in accordance with the Declaration of Helsinki
and had been approved by the ethics committee of theMedical Univer-
sity of Graz.
The groups did not differ in mean age (MPD=56.1 years (SD=8.5),
MHC = 55.4 (SD = 8.4); t(48) = 0.28, p = .778) and years of
education (MPD = 12.9 years (SD = 3.4), MHC = 13.2 (SD = 3.3);
t(48) = 0.30, p= .769).
Cognitive performance was assessed by the Test for Early Detection
of Dementia (TEDD) [32]. The scores of this scale range between 0 and
50. A score below 35 indicates a tentative dementia diagnosis and was
set as an exclusion criterion. The Cronbach's alpha of the TEDD is
0.88. None of the patients showed signs of cognitive impairment
(MPD = 45.1 (SD = 3.1), MHC = 44.4 (SD = 3.2); t(48) = 0.67, p =
.508). Additionally, PD patients and HC did not differ in their Beck De-
pression Inventory scores (BDI; MPD = 6.7 (SD = 7.0), MHC = 9.1
(SD= 6.4); t(48) = 0.32 (p= .752) [33].
Daily life functioning was assessed by the ‘Functional Assessment
Scale’ of the Uniﬁed Huntington's Disease Rating Scale (UHDRS), asking
for (paid) occupation, management of ﬁnancial affairs, independent
housekeeping, body care and mobility [34]. The scale ranges up to a
score of 25, with higher scores revealing better functioning. Cronbach's
alpha for the functional checklist is 0.95. PD patients showed lower
daily life functioning than healthy controls (MPD = 23.28 (SD= 2.44),
MHC = 24.72 (SD= 0.46); t(25.69) = 2.90 (p= .008).
Patients' meanmotor score assessed by the Uniﬁed Parkinson's Dis-
ease Rating Scale (UPDRS) was 34.2 (SD= 8.5) [35]. Eighteen patients
had right body side onset of motor symptoms and 7 had left-side
onset. Motor symptoms became manifest at a mean age of 50.1 years
(SD = 8.9), and at the time of testing the symptom duration was
M=6.0 years (SD=3.0) on average. The stage of disease was checked
with theHoehn andYahr rating score [36].Twenty-two patients showed
stage 2.0, one patient showed stage 2.5, and two patients showed stage
3.0. This indicates mild to moderate symptom intensity. With one ex-
ception all patients were treated with L-Dopa and/or a dopamine ago-
nist (pramipexole, ropinirole). The mean total L-Dopa equivalent daily
dosage was M = 459 mg (SD= 295.5) on average. However, medica-
tion was discontinued for 10 to 12 h prior to the experiment and was
continued only afterwards.2.2. Questionnaires
All participants answered the following scales:
The Questionnaire for the Assessment of Disgust Proneness (QADP)
measures disgust propensity and describes 37 situations, which have
to be judged on 5-point scales with regard to the experienced disgust
(0, ‘not disgusting’; 4, ‘very disgusting’). The ﬁve subscales are
a) death/deformation, b) body secretions, c) spoilage/decay, d) poor
hygiene, and e) oral rejection [37]. The Cronbach's alpha of the total
scale is .90.
The scale for theAssessment of Disgust Sensitivity (SADS) consists of
seven items addressing the appraisal of one's own disgust feelings
(e.g., ‘Experiencing disgust is stressful for me.’) and its control (e.g., ‘It
embarrasses me when I feel disgusted’) [38]. The Cronbach's alpha of
the scale is 0.85.
The Beck Depression Inventory (BDI, German version) consists of 21
items rated on 4-point scales [33]. A sum score of 18 or higher indicates
clinical relevance. The Cronbach's alpha is 0.88.
The trait scale of the State-Trait Anger Expression Inventory (STAXI;
German version) assesses the tendency of a person to experience,
express and control anger [39]. The questionnaire consists of four sub-
scales labeled ‘trait anger’, ‘anger suppression’ (anger in), ‘anger expres-
sion’ (anger out), and ‘anger control’. The 24 items are answered on
4-point scales (1 = almost never, 4 = almost ever). The Cronbach's
alpha ranges between .76 und .87.
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measures the frequency of anxious feelings [40]. The questionnaire con-
sists of 20 items which are answered on a 4-point scale (1 = almost
never, 4 = almost ever). The Cronbach's alpha of the scale is .88.
2.3. Stimuli and design (Fig. 1)
The stimulus material consisted of 30 pictures with emotional facial
expressions depicting fear (10), anger (10), and disgust (10) from the
Karolinska set [41]. Half of the posers were female, and half were
male. Also, the participants were presented with a total of 20 affective
scenes for the elicitation of fear (10) and disgust (10). Scenes wereFig. 1. Design and coursetaken from the International Affective Picture System (IAPS) [42] or de-
veloped by Schienle et al. [43]. Disgust-elicitingpictures included scenes
with animals (maggots, burying beetle on carrion, lollipop with cricket
andmealworm, an openedmussel, a slug, and earthworms), a dirty toi-
let, unappetizing food, an eczematous face, and an eczematous bum.
The fear-inducing pictures showed threatening situations either
through attacks of animals (‘dogwith its teeth bared’, IAPS 1300; gorilla,
IAPS 1660; a threatening bear, a tiger with itsmuzzle opened, and a bird
of preywith its catches spread, developed by the authors) or human at-
tacks (‘man threatening a woman with a knife’, IAPS 6350; ‘men with
pistol’, IAPS 6230; ‘war scene’, IAPS 6940; ‘masked robber’, IAPS 6370,
and a pursuit scene by night, developed by the authors). Since theof the experiment.
Table 1
Self-report data on affective traits.
PD HC t value P value
QADP total 1.98 (0.49) 2.07 (0.49) −0.60 .276
Death 1.29 (0.98) 0.94 (0.91) 1.30 .100
Body secretions 2.38 (0.64) 2.55 (0.71) −0.92 .180
Spoilage/decay 1.60 (0.69) 1.95 (0.63) −1.86 .035
Poor hygiene 2.05 (0.64) 2.46 (0.65) −2.27 .014
Oral rejection 2.60 (0.57) 2.38 (0.76) 1.16 .126
SADS 8.00 (4.51) 5.56 (5.34) 1.75 .043
STAI 39.52 (10.88) 34.60 (8.03) 1.82 .038
STAXI trait 17.40 (3.78) 18.08 (3.98) −0.62 .269
Anger in 15.20 (4.20) 16.36 (5.63) −0.83 .207
Anger out 11.28 (2.92) 11.80 (2.75) −0.65 .260
Anger control 21.84 (5.13) 25.32 (3.65) −2.76 .004
Notes. QADP: Questionnaire for the Assessment of Disgust Proneness; SADS: Scale for the
Assessment of Disgust Sensitivity; STAI: State Trait Anxiety Inventory (trait scale); STAXI:
State Trait Anger Expression Inventory (trait scales).
Table 2
Ratings of affective faces and scenes.
PD HC t value P value
Affective ratings of facial expressions: intensity
Fear 6.21 (1.51) 5.31 (1.93) 1.83 .037
Disgust 5.74 (1.70) 5.71 (1.65) 0.06 .476
Anger 7.53 (1.06) 7.59 (0.90) −0.19 .425
Affective ratings of facial expressions: accuracy
Fear 3.17 (1.80) 2.42 (1.75) 1.50 .071
Disgust 2.59 (1.80) 2.90 (1.96) −0.58 .283
Anger 5.03 (1.50) 5.51 (1.45) −1.14 .130
Affective ratings of scenes: intensity
Fear 6.64 (1.53) 5.74 (2.39) 1.60 .059
Disgust 6.02 (1.49) 5.41 (1.73) 1.34 .094
Anger (fear-inducing scenes) 3.74 (1.68) 3.54 (1.89) 0.38 .352
Anger (disgusting scenes) 2.85 (1.46) 2.08 (1.17) 2.07 .022
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ry had to be omitted.
Each picture was presented on a computer screen (15 in. diameter)
for amaximumof 15 s. The subjectswere asked to rate each picture on a
9-point scale within 15 s but could terminate the presentation earlier in
order to proceed with the rating. After the rating of a picture the next
picture was presented without any delay. For each facial expression
(fear, disgust, anger) subjects rated how intense the depicted person
had experienced the ﬁve basic emotions (happiness, fear, sadness,
anger, and disgust; e.g. ‘Please indicate how intense the depicted person
experienced disgust’: 1 = very little; 9 = very intense). For each affec-
tive scene (fear, and disgust) subjects rated how intense they had expe-
rienced the ﬁve basic emotions (happiness, fear, sadness, anger, and
disgust; e.g. ‘Please indicate how intense you experienced disgust
while viewing the picture’: 1 = very little, 9 = very intense). To avoid
position effects, the order of the two picture tasks (recognition vs. expe-
rience), the order of pictures, and the order of basic emotions that had to
be rated were randomized.
Summarizing, the features extracted for PD and HC were: disgust
propensity, disgust sensitivity, anxiety, anger expression, intensity and
recognition accuracy for fearful, disgusted and angry faces, intensity ex-
perience for fear- and disgust-eliciting scenes, and anger experience for
fear- and disgust-eliciting scenes.
2.4. Statistical analysis
All statistical analyseswere carried out using SPSS 22.0 forWindows.
We computed Student t-tests in order to compare questionnaire scores
between groups (PD, HC).
For the facial emotion recognition task we computed 2 × 3 ANOVAs
with the factors group (PD, HC) and emotion condition (fear,
disgust, and anger) in order to compare the target emotion ratings
(e.g., intensity of disgust for disgust faces, intensity of anger for anger
faces…).
Additionally, 2 × 5 ANOVAs were conducted separately for each tar-
get emotion rating (e.g., disgust ratings across all conditions), with the
between-subject factors group (PD, HC) and the repeated measure fac-
tor emotion condition (intensity rating of happiness, fear, sadness, dis-
gust, and anger).
Moreover, we conducted Student t-tests in order to compare recog-
nition accuracy between groups. Recognition accuracy was deﬁned as
the difference between the perceived intensity of a target emotion
and themean intensity of all non-target emotions for a speciﬁc facial ex-
pression (e.g., classiﬁcation accuracy of disgust recognition for a disgust
expression = disgust intensity minus mean intensity of non-target
emotions [happiness, fear, sadness, anger]).
For the emotion experience task we computed 2 × 5 ANOVAs sepa-
rately for fear and disgust ratings with the factors group (PD, HC) and
emotion condition (intensity rating of happiness, fear, sadness, disgust,
and anger).
Signiﬁcant effects of ANOVAswere followed upwith post-hoc t-tests.
As we formulated investigated directional hypotheses, one-sided t-tests
were calculated.
Associations between disease severity measures and affective pa-
rameters were analyzed with Pearson's correlations.
Alpha level signiﬁcance was set at .05 for all statistical tests. Cohen's
d was used as effect size measure.
3. Results
3.1. Questionnaires (Table 1)
Compared to the HC group PD patients displayed higher disgust
sensitivity (SADS; Cohen's d = 0.49) and lower anger control (STAXI;
d=0.78). Further, PD patients reported lower disgust for ‘poor hygiene’(d=0.64) and for ‘spoilage/decay’ of theQADP (d=0.53). Patients also
reported higher trait anxiety than HC (STAI; d= 0.51).
3.2. Emotion recognition (Table 2)
3.2.1. Intensity ratings
PD patients rated higher fear intensity for fearful faces than HC
(d = 0.52). However, groups did not differ in intensities of target
emotions for disgusted and angry faces.
3.2.2. Recognition accuracy
PD patients and HC did not differ in classiﬁcation accuracy for facial
disgust, fear and anger.
3.3. Emotion experience (Table 2)
PD patients perceived fear in fear-eliciting scenes slightly more in-
tense than HC (d=0.45) but there was no group difference for disgust.
As no reliable anger-eliciting scenes are provided by IAPS we have
compared anger experience in fear- and disgust-eliciting scenes. The
PD group reported more intense anger for disgusting scenes compared
to HC (d= 0.58) (Table 2).
3.4. Correlations (Figs. 2–5)
In PD patients disgust sensitivity (SADS) was negatively correlated
with daily life functioning (r = −0.55, p = .006) and recognition
accuracy of angry faces (r = −0.46, p = .022), and marginally
correlatedwith fear intensitywhen presentedwith fear-eliciting scenes
(r = 0.38, p= .065) (Fig. 2).
Fig. 2. Correlation between disgust sensitivity (SADS), daily life functioning, recognition
accuracy for angry faces and fear experience in PD patients.
Fig. 4. Correlation between disease duration, anger intensity perception for angry faces
and anger control (STAXI) in PD patients.
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gust experience and disgust recognition in PD patients (all p N .157).
However, trait anxiety (STAI) was positively correlated to fear intensity
ratings for fear-eliciting scenes (r= 0.49, p= .014) and intensity esti-
mation of fearful faces (r = 0.52, p = .008). Furthermore, intensity of
fear experience for fear-eliciting scenes and fear intensity estimation
for fearful faces were positively correlated (r = 0.61, p = .001)
(Fig. 3). Additionally, we found a positive correlation between anger
perception in fear-eliciting scenes and trait anger (STAXI; r = 0.53,
p= .006) as well as ‘anger in’ (r= 0.42, p= .038) in PD patients.
Concerning associations to disease severity,we found a negative cor-
relation between disease duration and estimated anger intensity for
angry faces (r =−0.43, p = .031) and a slightly negative correlation
to STAXI anger control (r =−0.37, p = .069) (Fig. 4). Motor impair-
ment (UPDRS) was negatively associated with daily life functioning
(r=−0.41, p= .042). Cognitive capacity (TEDD)was positively corre-
latedwith recognition accuracy of fearful faces in PD patients (r= 0.52,
p= .008) (Fig. 5).
For controls we found a positive correlation between disgust
propensity (mean QADP) and disgust intensity for disgusting scenes
(r= 0.54, p= .006). Anxiety (STAI) was negatively correlated to recog-
nition accuracy of disgusted faces (r =−0.49, p= .013).
4. Discussion
This study investigated different facets of affectivity and their
mutual relations in mild to moderate PD. The patient group reported
more problems in controlling anger and disgust feelings than healthyFig. 3.Correlation between trait anxiety (STAI), intensity of fear experience and fear inten-
sity for fearful faces in PD patients.controls, pointing to deﬁcits in the regulation of negative emotions. Pa-
tients with lower control of disgust feelings displayed worse function-
ing in everyday life, had more problems to accurately recognize angry
faces and additionally experienced slightly more fear when presented
with fear-eliciting scenes. In a recent study by Ille et al. [29]) we could
show that PD patients at an earlier disease stage showed reduction of
the gray matter volume in the OFC, a brain region which is relevant
for emotion control (e.g., Hooker and Knight [44]).
Further, PD patients reported less disgust feelings towards
poor hygiene and spoiled food than healthy controls. We did not mea-
sure olfactory function of PD patients in this study but olfactory dys-
function is known as one of the early signs in PD showing high
prevalence [45,46,47]. Therefore, it seems reasonable that olfactory im-
pairment leads to decreased disgust towards aversive smells like bodily
odors or spoiled food. Findings by Hummel et al. [45] showed that PD
patients rated unpleasant stimuli smelling like rotten eggs less intense
and perceived it as more pleasant than healthy controls. Furthermore,
ﬁndings by Ille et al. [29] revealed GMV reduction in the central olfacto-
ry system (orbitofrontal and piriform cortex) in PD associated with
olfactory-related disgust propensity. Also ﬁndings in patients with
Huntington's disease, which is also associated with olfactory dysfunc-
tion, revealed less disgust than healthy controls when presented with
disgusting smells [48].
PD patients displayed elevated trait anxiety that was associated
with more intense fear experience, and higher trait anger was
associated with more intense anger ratings. This ﬁnding met our
expectations for a positive relationship between affective traits and
affective states. However, disgust propensity and disgust sensitivityFig. 5. Correlation between cognitive capacity (TEDD) and recognition accuracy of fearful
faces in PD patients.
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sociations between different aspects of disgust could be altered by
olfactory dysfunction and patients' problems in controlling disgust
feelings.
The intensity and accuracy ratings for the displayed negative facial
emotions indicated no perception deﬁcit in the clinical group. Further-
more, PD patients andHC gave comparable intensity ratings for disgust-
ing and fear-eliciting scenes. However, PD patients showed an anger
bias when presented with disgusting scenes which was associated
with their trait anger and could be another indication of problems
with anger regulation.
Our ﬁndings replicate previous reports on intact facial emotion
decoding in PD by several authors [13–17]. Cohen et al. [14] who inves-
tigated a nondemented and nondepressed patient group could not de-
tect any impairment in recognition accuracy for emotional faces but
PD patients showed delayed responses. However, contrary to our
study, there was no limitation in response time.
Itmust bementioned that our ﬁndings aremost likely not due to low
statistical power since PDpatients evenwere better in recognizing facial
fear, an emotion that is difﬁcult to decode.
One argument for intact emotion decodingwould be that our patient
group was not afﬂicted by depressive symptoms or cognitive impair-
ment. However, several studies investigating non-depressed and non-
demented PD patients have reported impaired facial emotion recogni-
tion [5,8].
Furthermore, themedication had been discontinued for 12 h prior to
the investigation. It might be expected that interrupting dopatherapy is
a disadvantage for emotion processing, but Péron, et al. [12] assumed a
potentially adverse effect of dopaminergic therapy on affective abilities
in earlier stages of the disease (see also Delaveau et al. [49]).
One further explanation for unimpaired facial emotion recognition
in PD could be due to compensatory mechanisms as long as the
disease is less advanced. Findings by Anders et al. [50] who investigated
positive facial expressions in Parkin mutation carriers revealed
that compensatory (increased) activity in the ventrolateral premotor
cortex during emotion processing can diminish recognition impair-
ments. Furthermore, Wieser et al. [16] reported that early visual dis-
crimination of facial expressions was diminished on electrocortical
level in PD, whereas patients showed no impairments in emotion
recognition as measured by affective ratings. The authors suggest that
the absence of behavioral impairmentmay point to compensatory strat-
egies by intact pathways, e.g., premotor, somatosensory and prefrontal
areas.
However, it is not known until now, which factors will promote
compensatory mechanisms. Previous ﬁndings reveal no strong associa-
tion between disease severity and emotion decoding capacity. In our
study disease duration was negatively associated to correct classiﬁca-
tion of angry faceswhich could indicate that compensatorymechanisms
work less well with disease progression.
Compensatory mechanisms could also be adjusted to olfactory deﬁ-
cits in PD. Recent ﬁndings by Lemogne et al. [51] revealed decreased
error rates for facial fear and disgust in patients with long-lasting anos-
mia. The authors suggested that anosmic patients may compensate
their inability to detect environmental hazards through olfaction by an
increased ability to detect fear or disgust as facially expressed by others.
Simulation theories could also provide an explanation for intact
emotion capacity of facial emotion decoding in PD. Simulation ap-
proaches assume that the ability to recognize the emotions expressed
by other individuals relies, at least in part, on processes that internally
simulate the same emotional state in themselves [52,53]. Thus, if emo-
tion experience is unimpaired in PD this could be the substrate for ap-
propriate decoding of facial emotions.
However, emotion recognition and experience were correlated only
for fear in PD patients, while for disgust and anger there was no rela-
tionship. This may indicate that emotion experience and recognition
of facial emotions are processed differently. Presumably, also furtherinformation processingmechanisms will be used for emotion decoding,
e.g., cognitive processing of facial features [54].
Intact emotion recognition and experience in PD patients are also in
concordance with results by Wabnegger et al. [17] and Ille et al. [29], as
PD patients in this study displayed no alterations of regions that are typ-
ically involved in emotion experience (e.g., amygdala). Therefore, de-
generations of these regions can appear at a more progressive disease
stage.
Our patient group revealed lowered daily life functionality that was
negatively correlated to motor impairment. Moreover, the capacity to
accurately recognize angry faceswas negatively related to disease dura-
tion, and anger control slightly worsened with course of the disease.
However, there was no relationship between motor impairment in PD
patients and their emotion recognition capacity. Previous ﬁndings on
the role of motor impairment in emotion recognition are inconsistent,
but effects seem to be rather slight [7,15]. Additionally, in the patient
group a lower cognitive capacity was associated with poorer decoding
of fearful faces. This indicates that with disease progression not only a
worsening of everyday life functions but also of social capacity must
be considered.
In conclusion, PD patients reported more problems with control of
disgust and anger feelings. Lowered control of disgust feelingswas asso-
ciated with inferior daily life and social functionality, and anger control
slightly worsened with disease duration. However, it must be men-
tioned that further studieswill be necessary for estimating emotion reg-
ulation in PDwhich should include experimental and imagingmethods.
Additionally, the PD group displayed lower disgust towards aversive
smells like bodily odors or spoiled food. This could be associatedwith ol-
factory impairment, one of the early signs in PD. However, PD patients
displayed unimpaired facial emotion decoding and emotion experience.
Nevertheless, data also suggest to a deterioration of emotion recogni-
tion capacitywith the course of thedisease. Therefore, it can be assumed
that PD patients use compensatorymechanisms as long as the disease is
less advanced. Thus, PD patients without dementia and depression may
yield appropriate emotion recognition and experience in earlier disease
stages. By contrast, problems with emotion regulation can appear al-
ready earlier in the course of the disease.Acknowledgments
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